Old Web
English
Sign In
Acemap
>
Paper
>
轉移性大腸直腸癌病人以regorafenib合併FOLFIRI 配方為第四線治療藥物時,以UGT1A1基因多型性做為irinotecan劑量調整的病例報告
轉移性大腸直腸癌病人以regorafenib合併FOLFIRI 配方為第四線治療藥物時,以UGT1A1基因多型性做為irinotecan劑量調整的病例報告
2014
lujianyu
Yeyong Song
Huangjing Wen
mazhengren
Fangrong Yu
wangzhaoyuan
Chein-Yu Lu
Yung-Sung Yeh
Ching-Wen Huang
Cheng-Jen Ma
Fang-Jung Yu
Jaw-Yuan Wang
Keywords:
Metastatic colon cancer
Regorafenib
Oncology
Medicine
Internal medicine
Irinotecan
dose escalation
Correction
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]